All lobbying filings
LMH STRATEGIC SOLUTIONS
Lobbying for ALKERMES, INC. · Biopharmaceutical company
Filing
1st Quarter - Report
Bills named in this filing
1
Lobbying activity
1
Medicare/Medicaid issues. Medicaid drug rebate program. Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. H.R.946: ORPHAN Cures Act. Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically. Provide guidance and advice regarding mental health, public health and regulatory reform.